AI-generated summary
The authors retrospectively reviewed 72 Chinese patients with acquired bilateral nevus of Ota-like macules treated with a 730-nm picosecond laser alone between 2020 and 2024. They report an overall effective rate of 75% after an average of 2.42 sessions, with improvement scores rising across sessions in a subgroup of 41 patients, and no hypopigmentation observed.
- Participants
- 72
- Who or what was studied
- Chinese patients with acquired bilateral nevus of Ota-like macules and Fitzpatrick skin types III to IV
- Wavelengths
- 730 nm
- Limits stated in the abstract
- The retrospective design, lack of a control group, and assessment by blinded dermatologists from photographs are limitations; the abstract does not describe a control arm or long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.